Table 1

Comparison of clinical and epidemiologic characteristics of the patients with isolates resistant to isoniazid and rifampicin by the GenoType® MTBDRplus assay

Drug susptibility pattern

Characteristic

Number of

patients

INHa

RIFb

MDRc


Age

< 39 years

96

2

3

2

40-60 years

27

0

1

0

> 60 years

2

0

0

0


Gender

Male

75

0

2

0

Female

50

2

2

2


TB history

New

116

1

3

2

Retreatment

9

1

1

0


HIV status

Positive

55

1

1

2

Negative

26

0

1

0

Unknown

44

1

2

0


Smear result

1-10/10-100HPF

30

0

1

1

> 1AFB/HPF

95

2

3

1


aMonoresistance to isoniazid; bMonoresistance to rifampicin; cResistance to both isoniazid and rifampicin.

Bazira et al. BMC Clinical Pathology 2010 10:5   doi:10.1186/1472-6890-10-5

Open Data